 |
|
Effects of Second-Generation Antipsychotic Medication on Smooth Pursuit Performance in Antipsychotic-Naive Schizophrenia
Rebekka Lencer, MD;
Andreas Sprenger, MA;
Margret S. H. Harris, MA;
James L. Reilly, PhD;
Matcheri S. Keshavan, MD;
John A. Sweeney, PhD
Arch Gen Psychiatry. 2008;65(10):1146-1154.
Context Analyses of smooth pursuit eye movement parameters in patients with schizophrenia provide information about the integrity of neural networks mediating motion perception, sensorimotor transformation, and cognitive processes such as prediction. Although pursuit eye tracking deficits have been widely reported in schizophrenia, the integrity of discrete components of pursuit responses and the effect of second-generation antipsychotic medication on them are not well established.
Objective To examine different components of smooth pursuit performance in antipsychotic-naive patients with schizophrenia before and after treatment with second-generation antipsychotic medication.
Design, Setting, and Participants Thirty-three antipsychotic-naive patients with schizophrenia performed 3 different smooth pursuit paradigms designed to evaluate specific components of the pursuit response. All of the patients were retested after 6 weeks of treatment with risperidone or olanzapine. Testing was also performed with 39 matched healthy individuals. Thirteen patients and 21 healthy participants were retested after 26 and 52 weeks.
Main Outcome Measures Pursuit initiation, maintenance gain (ratio of eye velocity over target velocity), and frequency of catch-up saccades during pursuit maintenance.
Results Prior to treatment, pursuit gain when tracking less predictable ramp targets tended to be reduced, latency of pursuit initiation was speeded, and catch-up saccade frequency was increased during predictive pursuit. After antipsychotic treatment initiation, pursuit gain decreased with ramp targets, indicating treatment-emergent impairments in sensorimotor processing. No changes were observed for predictive pursuit. Exploratory analyses in the subgroup with follow-up to 1 year revealed that these effects continued through long-term follow-up with some partial normalization at 1 year. Deficits were unrelated to drug dosage and clinical ratings.
Conclusions Impaired sensorimotor function was observed after initiation of second-generation antipsychotic medications, which may be explained by their serotonergic antagonism of brainstem sensorimotor systems. Predictive mechanisms supported by frontostriatal-cerebellar circuitry were not affected by treatment initiation and appear able to compensate for treatment-emergent sensorimotor impairments during predictive tracking.
Author Affiliations: Departments of Psychiatry and Psychotherapy (Dr Lencer) and Neurology (Mr Sprenger), University of Lübeck, Lübeck, Germany; Center for Cognitive Medicine, University of Illinois at Chicago (Drs Lencer, Reilly, and Sweeney and Ms Harris); and Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, Michigan (Dr Keshavan).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
This Month in Archives of General Psychiatry
Arch Gen Psychiatry. 2008;65(10):1115.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Short-term Effects of Antipsychotic Treatment on Cerebral Function in Drug-Naive First-Episode Schizophrenia Revealed by "Resting State" Functional Magnetic Resonance Imaging
Lui et al.
Arch Gen Psychiatry 2010;67:783-792.
ABSTRACT
| FULL TEXT
Neurobehavioral Abnormalities in First-Degree Relatives of Individuals With Autism
Mosconi et al.
Arch Gen Psychiatry 2010;67:830-840.
ABSTRACT
| FULL TEXT
|
